Poughkeepsie, NY, United States of America

Carl Alan Busacca

This inventor holds 17 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in HCV Inhibitors. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2001-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl Alan Busacca. Retrieved from https://idiyas.com/inventor/carl-alan-busacca

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 66(Granted Patents)

Company Filing History:

12 out of 1,564

Boehringer Ingelheim International Gmbh

patents

5 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

Years Active: 2001-2013

Loading Chart...

Areas of Expertise:

HCV Inhibitors

Macrocyclic Compounds

Electronically Tuned Ligands

Acyclic Protease Inhibitors

Secondary Phosphines

Dipeptide Synthesis

Asymmetric Hydrogenation

Non-Nucleoside Inhibitors

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8519176 - Process for preparation of substituted P-aminophenol (2013-08-27),

2. 8362035 - Crystalline forms of a potent HCV inhibitor (2013-01-29),

3. 8232293 - Crystalline forms of a potent HCV inhibitor (2012-07-31),

4. 8222369 - Process for preparing macrocyclic compounds (2012-07-17),

5. 8212049 - Electronically tuned ligands for asymmetric hydrogenation (2012-07-03),

6. 8101765 - Process for preparing acyclic HCV protease inhibitors (2012-01-24),

7. 8017771 - Process for preparing acyclic HCV protease inhibitors (2011-09-13),

8. 7994335 - Electronically tuned ligands for asymmetric hydrogenation (2011-08-09),

9. 7608614 - Process for preparing macrocyclic compounds (2009-10-27),

10. 7544798 - Process for preparing macrocyclic compounds (2009-06-09),

11. 7514557 - Process for preparing acyclic HCV protease inhibitors (2009-04-07),

12. 7491851 - Method for generating secondary phosphines (2009-02-17),

13. 7309700 - Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3′-e] [1,4]diazepin-6-one (2007-12-18),

14. 7256314 - Method for generating secondary phosphines (2007-08-14),

15. 7186827 - Dipeptide synthesis (2007-03-06),

Title: The Innovative Journey of Inventor Carl Alan Busacca

Introduction: Carl Alan Busacca, a talented inventor hailing from Poughkeepsie, NY, has made significant contributions to the world of innovations with his creative mind and dedication to problem-solving.

Latest Patents: Carl Alan Busacca holds several patents in various fields, including technology, engineering, and healthcare. His most recent patents focus on cutting-edge advancements in renewable energy solutions and sustainable materials.

Career Highlights: Throughout his illustrious career, Carl Alan Busacca has been recognized for his groundbreaking inventions that have revolutionized industries. His work has not only improved efficiency but has also had a positive impact on environmental sustainability.

Collaborations: Carl Alan Busacca has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life. His partnerships have been instrumental in turning his concepts into tangible products that benefit society.

Conclusion: In conclusion, Carl Alan Busacca's passion for innovation and his relentless drive to push boundaries have solidified his position as a respected inventor in the field. His contributions continue to inspire future generations of inventors to think outside the box and create solutions that shape a better tomorrow.

Profile summary based on public USPTO records.